![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University of Copenhagen |
---|---|
Information provided by: | University of Copenhagen |
ClinicalTrials.gov Identifier: | NCT00465036 |
Randomized trial to test the effect of flaxseed fractions on appetite regulation and instestinal lipid absorption
Condition | Intervention |
---|---|
Obesity |
Behavioral: Whole flaxseeds, flaxseed mucilage, glucomannan |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Active Control, Crossover Assignment, Efficacy Study |
Official Title: | Effect of Whole Flaxseeds and Flaxseed Mucilage on Lipid Absorption, Glucoseand Insulin Metabolsim and Appetite Regulation |
Estimated Enrollment: | 18 |
Study Start Date: | October 2006 |
Estimated Study Completion Date: | May 2007 |
Randomized multiple crossover trial in 18 healthy males aged 18 to 40 years each are required to complete a total of five iso-caloric meal tests lasting app. 8½ hours. Test meals will be given as breakfast meals, in which different fractions of flaxseeds are incorporated into baked products. Appetite will be registered using visual analogue scales during 7 hours after the tst meal and a total of 10 blood samples will be drawn to evaluate TAG in chylomicrons, plasma LDL, HDL and total cholesterol, plasma TAG, insulin, glucose and appetite hormone levels. At the end of the test day an ad libitum meal will be served and food intake registered.
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | KF 01 309595, B226 |
Study First Received: | April 23, 2007 |
Last Updated: | April 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00465036 |
Health Authority: | United States: Institutional Review Board |
fat absorption fibres |
Body Weight Signs and Symptoms Obesity (1-6)-alpha-glucomannan |
Nutrition Disorders Overweight Overnutrition Insulin |
Therapeutic Uses Gastrointestinal Agents Cathartics Pharmacologic Actions |